Specific immunotherapy normalizes tryptophan concentrations in patients with allergic rhinitis

International Archives of Allergy and Immunology

Volumn 159, Issue 4, 2012, Pages 416-421

  Kofler, H ^a   Kurz, K ^b   Grander, G ^a   Fuchs, D ^b  

^a Allergy Outpatient Clinic Hall   (Austria)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Indoleamine 2,3 dioxygenase; Pollinosis; Specific immunotherapy; Tryptophan

Indexed keywords

ALLERGOID VACCINE; ALUTARD; ANTIHISTAMINIC AGENT; INDOLEAMINE 2,3 DIOXYGENASE; KYNURENINE; NEOPTERIN; POLLEN ANTIGEN; POLLEN EXTRACT; POLLINEX QUATTRO; STEROID; TRYPTOPHAN; UNCLASSIFIED DRUG; VACCINE;

ADULT; ALLERGIC REACTION; ALLERGIC RHINITIS; AMINO ACID BLOOD LEVEL; ARTICLE; BOOSTER IMMUNOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; FOLLOW UP; GRASS POLLEN; HAY FEVER; HUMAN; HUMAN TISSUE; IMMUNOTHERAPY; MALE; POLLEN ALLERGY; PRIORITY JOURNAL; RECURRENT DISEASE; SPECIFIC IMMUNOTHERAPY; TREATMENT RESPONSE; TRYPTOPHAN METABOLISM;

ADULT; CYTOKINES; FEMALE; HUMANS; IMMUNIZATION, SECONDARY; IMMUNOTHERAPY; KYNURENINE; MALE; NEOPTERIN; POACEAE; POLLEN; RHINITIS, ALLERGIC, SEASONAL; TH1-TH2 BALANCE; TRYPTOPHAN; VACCINES;

EID: 84864264112     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000338937     Document Type: Article

References (39)

1. Lucey DR, Clerici M, Shearer GM: Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases. Clin Microbiol Rev 1996; 9: 532-562. (Pubitemid 26366537)
2. Romagnani S: Immunologic influences on allergy and the TH1/TH2 balance. J Allergy Clin Immunol 2004; 113: 395-400. (Pubitemid 38338939)
3. Yoshida R., Imanishi J, Oku T, Kishida T, Hayaishi O: Induction of pulmonary indoleamine 2,3-dioxygenase by interferon. Proc Natl Acad Sci USA 1981; 78: 129-132. (Pubitemid 11131252)
4. Pfefferkorn ER: Interferon gamma blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cells to degrade tryptophan. Proc Natl Acad Sci USA 1984; 81: 908-912. (Pubitemid 14197611)
5. Moser M, Murphy KM: Dendritic cell regulation of TH1-TH2 development. Nat Immunol 2000; 3: 199-205.
6. Mellor AL, Munn DH: IDO expression by dendritic cells: Tolerance and tryptophan catabolism. Nat Rev Immunol 2004; 4: 762-774. (Pubitemid 39336293)
7. Hayashi T, Beck L, Rossetto C, Gong X, Takikawa O, Takabayashi K, Broide DH, Carson DA, Raz E: Inhibition of experimental asthma by indoleamine 2,3-dioxygenase. J Clin Invest 2004; 114: 270-279. (Pubitemid 39071632)
8. Xu H, Oriss TB, Fei M, Henry AC, Melgert BN, Chen L, Mellor AL, Munn DH, Irvin CG, Ray P, Ray A: Indoleamine 2,3-dioxygenase in lung dendritic cells promotes Th2 responses and allergic inflammation. Proc Natl Acad Sci USA 2008; 105: 6690-6695. (Pubitemid 351754568)
9. Taher YA, Piavaux BJ, Gras R, van Esch BC, Hofman GA, Bloksma N, Henricks PA, van Oosterhout AJ: Indoleamine 2,3-dioxygenase-dependent tryptophan metabolites contribute to tolerance induction during allergen immunotherapy in a mouse model. J Allergy Clin Immunol 2008; 121: 983-991.
10. Le AV, Broide DH: Indoleamine-2,3-dioxygenase modulation of allergic immune responses. Curr Allergy Asthma Rep 2006; 6: 27-31.
11. Fuchs D, Möller AA, Reibnegger G, Stöckle E, Werner ER, Wachter H: Decreased serum tryptophan in patients with HIV-1 infection correlates with increased serum neopterin and with neurologic/psychiatric symptoms. J Acquir Immune Defic Syndr 1990; 3: 873-876. (Pubitemid 20330669)
12. Huengsberg M, Winer JB, Gompels M, Round R, Ross J, Shahmanesh M: Serum kynurenine-To-Tryptophan ratio increases with progressive disease in HIV-infected patients. Clin Chem 1998; 44: 858-862. (Pubitemid 28176030)
13. Schroecksnadel K, Wirleitner B, Winkler C, Fuchs D: Monitoring tryptophan metabolism in chronic immune activation. Clin Chim Acta 2006; 364: 82-90. (Pubitemid 43120630)
14. Werner ER, Bitterlich G, Fuchs D, Hausen A, Reibnegger G, Szabo G, Dierich MP, Wachter H: Human macrophages degrade tryptophan upon induction by interferon-Gamma. Life Sci 1987; 41: 273-280. (Pubitemid 17109654)
15. Wirleitner B, Reider D, Ebner S, Böck G, Widner B, Jaeger M, Schennach H, Romani N, Fuchs D: Monocyte-derived dendritic cells release neopterin. J Leukoc Biol 2002; 72: 1148-1153. (Pubitemid 36008885)
16. Huber C, Batchelor JR, Fuchs D, Hausen A, Lang A, Niederwieser D, Reibnegger G, Swetly P, Troppmair J, Wachter H: Immune response-associated production of neopterin- Release from macrophages primarily under control of interferon-Gamma. J Exp Med 1984; 160: 310-316. (Pubitemid 14089799)
17. Murr C, Widner B, Wirleitner B, Fuchs D: Neopterin as a marker for immune system activation. Curr Drug Metab 2002; 3: 175-187. (Pubitemid 34326529)
18. Raitala A, Karjalainen J, Oja SS, Kosunen TU, Hurme M: Indoleamine 2,3-dioxygenase (IDO) activity is lower in atopic than in non-atopic individuals and is enhanced by environmental factors protecting from atopy. Mol Immunol 2006; 43: 1054-1056. (Pubitemid 41814423)
19. von Bubnoff D, Fimmers R, Bogdanow M, Matz H, Koch S, Bieber T: Asymptomatic atopy is associated with increased indoleamine 2,3-dioxygenase activity and interleukin-10 production during seasonal allergen exposure. Clin Exp Allergy 2004; 34: 1056-1063. (Pubitemid 38969541)
20. Sekigawa T, Tajima A, Hasegawa T, Hasegawa Y, Inoue H, Sano Y, Matsune S, Kurono Y, Inoue I: Gene-Expression profiles in human nasal polyp tissues and identification of genetic susceptibility in aspirin-intolerant asthma. Clin Exp Allergy 2009; 39: 972-981.
21. Kositz C, Schroecksnadel K, Grander G, Schennach H, Kofler H, Fuchs D: Serum tryptophan concentration in patients predicts outcome of specific immunotherapy with pollen extracts. Int Arch Allergy Immunol 2008; 147: 35-40.
22. Ciprandi G, De Amici M, Tosca M, Fuchs D: Tryptophan metabolism in allergic rhinitis: The effect of pollen allergen exposure. Hum Immunol 2010; 71: 911-915.
23. Chardonnet Y: Study of the experimental immunity of guinea pigs against mumps virus. II. Research on the mechanism of appearance of complement fixing antibodies after secondary immunization (booster phenomenon) (in French). Rev Immunol Ther Antimicrob 1958; 22: 191-221.
24. Ebner C, Kraft D, Ebner H: Booster immunotherapy (BIT). Allergy 1994; 49: 38-42.
25. Widner B, Werner ER, Schennach H, Wachter H, Fuchs D: Simultaneous measurement of serum tryptophan and kynurenine by HPLC. Clin Chem 1997; 43: 2424-2426. (Pubitemid 28022985)
26. Laich A, Neurauter G, Widner B, Fuchs D: More rapid method for simultaneous measurement of tryptophan and kynurenine by HPLC. Clin Chem 2002; 48: 579-581. (Pubitemid 34174597)
27. Eder W, Ege MJ, von Mutius E: The asthma epidemic. N Engl J Med 2006; 355: 2226-2235. (Pubitemid 44791164)
28. Weiss G, Murr C, Zoller H, Haun M, Widner B, Ludescher C, Fuchs D: Modulation of neopterin formation and tryptophan degradation by Th1- And Th2-derived cytokines in human monocytic cells. Clin Exp Immunol 1999; 116: 435-440. (Pubitemid 29258092)
29. Gros E, Petzold S, Maintz L, Bieber T, Novak N: Reduced IFN- receptor expression and attenuated IFN- response by dendritic cells in patients with atopic dermatitis. J Allergy Clin Immunol 2011; 128: 1015-1021.
30. Mayersbach P, Fuchs D, Schennach H: Performance of fully automated quantitative neopterin measurements in a routine voluntary blood donations setting. Clin Chem Lab Med 2009; 48: 373-377.
31. Chen Y, Guillemin GJ: Kynurenine pathway metabolites in humans: Disease and healthy states. Int J Tryptophan Res 2009; 2: 1-19.
32. Kharitonov SA, Yates D, Robbins RA, Logan-Sinclair R, Shinebourne EA, Barnes PJ: Increased nitric oxide in exhaled air of asthmatic patients. Lancet 1994; 343: 133-135. (Pubitemid 24028638)
33. Kharitonov SA, Rajakulasingam K, O'Connor B, Durham SR, Barns PJ: Nasal NO is increased in patients with asthma and allergic rhinitis and may be modulated by nasal glucocorticoids. J Allerg Clin Immunol 1997; 99: 58-64. (Pubitemid 27074898)
34. Ciprandi G, Tosca M, Fuchs D: Nitric oxide metabolites in allergic rhinitis: The effect of pollen allergen exposure. Allergol Immunopathol 2011; 39: 326-329.
35. Thomas SR, Terentis AC, Cai H, Takikawa O, Levina A, Lay PA, Freewan M, Stocker R: Post-Translational regulation of human indoleamine 2,3-dioxygenase activity by nitric oxide. J Biol Chem 2007; 282: 23778-23787. (Pubitemid 47328013)
36. Ciprandi G, Fuchs D: Tryptophan, neopterin and nitrite in allergy. Allergy (in press
37. Sun J, Sukhova GK, Wolters PJ, Yang M, Kitamoto S, Libby P, MacFarlane LA, Mallen-St Clair J, Shi GP: Mast cells promote atherosclerosis by releasing proinflammatory cytokines. Nat Med 2007; 13: 719-724. (Pubitemid 46889760)
38. Koarai A, Ichinose M, Sugiura H, Yamagata S, Hattori T, Shirato K: Allergic airway hyperresponsiveness and eosinophil infiltration is reduced by a selective iNOS inhibitor, 1400W, in mice. Pulm Pharmacol Ther 2000; 13: 267-275.
39. Singh D, Richards D, Knowles RG, Schwartz S, Woodcock A, Langley S, O'Connor BJ: Selective inducible nitric oxide synthase inhibition has no effect on allergen challenge in asthma. Am J Respir Crit Care Med 2007; 176: 988-993. (Pubitemid 350127842)